Machine learning offers considerable potential for streamlining and transforming routine information processes in life sciences — but could more creative applications of artificial intelligence take things further still? AMPLEXOR’s Siniša Belina asse
Dr Andrew Rut, CEO of SaaS provider My Meds & Me discusses why AI can revolutionise drug development and healthcare but caution over data is critical for success.
In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy.
According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data.
A survey from The Pistoia Alliance has revealed that nearly three-quarters (72%) of life science professionals believe their industry is behind the curve in the development of artificial intelligence (AI).
As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area.
New research from Oracle Health Services in partnership with Informa Engage/Pharma Intelligence has revealed that more than 60% of drug safety experts are planning to use artificial intelligence (AI) to improve the speed and security
Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets.
